Effect of Acetazolamide vs Placebo on Duration of Invasive Mechanical Ventilation Among Patients With Chronic Obstructive Pulmonary Disease
Author(s) -
Christophe Faisy,
Ferhat Meziani,
Benjamin Planquette,
M. Clavel,
Arnaud Gacouin,
Caroline Bornstain,
Francis Schneider,
Alexandre Duguet,
Sébastien Gibot,
Nicolas Lerolle,
Jean-Damien Ricard,
Olivier Sanchez,
Michel Djibré,
J.-L. Ricôme,
Antoine Rabbat,
Nicholas Heming,
Saı̈k Urien,
Maxime Esvan,
Sandrine Katsahian
Publication year - 2016
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2016.0019
Subject(s) - medicine , acetazolamide , mechanical ventilation , copd , anesthesia , placebo , randomized controlled trial , metabolic alkalosis , intensive care unit , intubation , alkalosis , ventilation (architecture) , surgery , acidosis , mechanical engineering , engineering , alternative medicine , pathology
Acetazolamide has been used for decades as a respiratory stimulant for patients with chronic obstructive pulmonary disease (COPD) and metabolic alkalosis, but no large randomized placebo-controlled trial is available to confirm this approach.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom